Example of EPMA Journal format
Recent searches

Example of EPMA Journal format Example of EPMA Journal format Example of EPMA Journal format Example of EPMA Journal format Example of EPMA Journal format Example of EPMA Journal format Example of EPMA Journal format Example of EPMA Journal format Example of EPMA Journal format Example of EPMA Journal format Example of EPMA Journal format Example of EPMA Journal format Example of EPMA Journal format Example of EPMA Journal format Example of EPMA Journal format Example of EPMA Journal format Example of EPMA Journal format Example of EPMA Journal format
Sample paper formatted on SciSpace - SciSpace
This content is only for preview purposes. The original open access content can be found here.
Look Inside
Example of EPMA Journal format Example of EPMA Journal format Example of EPMA Journal format Example of EPMA Journal format Example of EPMA Journal format Example of EPMA Journal format Example of EPMA Journal format Example of EPMA Journal format Example of EPMA Journal format Example of EPMA Journal format Example of EPMA Journal format Example of EPMA Journal format Example of EPMA Journal format Example of EPMA Journal format Example of EPMA Journal format Example of EPMA Journal format Example of EPMA Journal format Example of EPMA Journal format
Sample paper formatted on SciSpace - SciSpace
This content is only for preview purposes. The original open access content can be found here.
open access Open Access
recommended Recommended

EPMA Journal — Template for authors

Publisher: Springer
Categories Rank Trend in last 3 yrs
Health Policy #5 of 242 up up by 5 ranks
Biochemistry (medical) #5 of 54 up up by 5 ranks
Drug Discovery #17 of 145 up up by 15 ranks
journal-quality-icon Journal quality:
High
calendar-icon Last 4 years overview: 143 Published Papers | 1293 Citations
indexed-in-icon Indexed in: Scopus
last-updated-icon Last updated: 12/09/2022
Related journals
Insights
General info
Top papers
Popular templates
Get started guide
Why choose from SciSpace
FAQ

Related Journals

open access Open Access
recommended Recommended

Taylor and Francis

Quality:  
High
CiteRatio: 3.2
SJR: 1.216
SNIP: 3.119
open access Open Access

Taylor and Francis

Quality:  
High
CiteRatio: 8.2
SJR: 1.864
SNIP: 1.641
open access Open Access
recommended Recommended

SAGE

Quality:  
High
CiteRatio: 4.3
SJR: 0.603
SNIP: 1.079
open access Open Access

Hindawi

Quality:  
High
CiteRatio: 6.3
SJR: 1.164
SNIP: 1.413

Journal Performance & Insights

CiteRatio

SCImago Journal Rank (SJR)

Source Normalized Impact per Paper (SNIP)

A measure of average citations received per peer-reviewed paper published in the journal.

Measures weighted citations received by the journal. Citation weighting depends on the categories and prestige of the citing journal.

Measures actual citations received relative to citations expected for the journal's category.

9.0

17% from 2019

CiteRatio for EPMA Journal from 2016 - 2020
Year Value
2020 9.0
2019 7.7
2018 6.3
2017 5.8
2016 5.8
graph view Graph view
table view Table view

1.177

7% from 2019

SJR for EPMA Journal from 2016 - 2020
Year Value
2020 1.177
2019 1.263
2018 1.085
2017 0.807
2016 0.814
graph view Graph view
table view Table view

1.422

3% from 2019

SNIP for EPMA Journal from 2016 - 2020
Year Value
2020 1.422
2019 1.469
2018 1.208
2017 1.296
2016 1.259
graph view Graph view
table view Table view

insights Insights

  • CiteRatio of this journal has increased by 17% in last years.
  • This journal’s CiteRatio is in the top 10 percentile category.

insights Insights

  • SJR of this journal has decreased by 7% in last years.
  • This journal’s SJR is in the top 10 percentile category.

insights Insights

  • SNIP of this journal has decreased by 3% in last years.
  • This journal’s SNIP is in the top 10 percentile category.

EPMA Journal

Guideline source: View

All company, product and service names used in this website are for identification purposes only. All product names, trademarks and registered trademarks are property of their respective owners.

Use of these names, trademarks and brands does not imply endorsement or affiliation. Disclaimer Notice

Springer

EPMA Journal

Approved by publishing and review experts on SciSpace, this template is built as per for EPMA Journal formatting guidelines as mentioned in Springer author instructions. The current version was created on 12 Sep 2022 and has been used by 115 authors to write and format their manuscripts to this journal.

Health Policy

Biochemistry, medical

Drug Discovery

Medicine

i
Last updated on
12 Sep 2022
i
ISSN
1878-5077
i
Impact Factor
Low - 0.486
i
Open Access
No
i
Sherpa RoMEO Archiving Policy
Green faq
i
Plagiarism Check
Available via Turnitin
i
Endnote Style
Download Available
i
Bibliography Name
SPBASIC
i
Citation Type
Numbered
[25]
i
Bibliography Example
Blonder GE, Tinkham M, Klapwijk TM. Transition from metallic to tunneling regimes in superconducting microconstrictions: Excess current, charge imbalance, and supercurrent conversion. Phys Rev B. 1982;25(7):4515–4532.

Top papers written in this journal

open accessOpen access Journal Article DOI: 10.1186/1878-5085-4-7
Pitfalls and limitations in translation from biomarker discovery to clinical utility in predictive and personalised medicine
Elisabeth Drucker, Kurt Krapfenbauer1
25 Feb 2013 - The Epma Journal

Abstract:

Since the emergence of the so-called omics technology, thousands of putative biomarkers have been identified and published, which have dramatically increased the opportunities for developing more effective therapeutics. These opportunities can have profound benefits for patients and for the economics of healthcare. However, t... Since the emergence of the so-called omics technology, thousands of putative biomarkers have been identified and published, which have dramatically increased the opportunities for developing more effective therapeutics. These opportunities can have profound benefits for patients and for the economics of healthcare. However, the transfer of biomarkers from discovery to clinical practice is still a process filled with lots of pitfalls and limitations, mostly limited by structural and scientific factors. To become a clinically approved test, a potential biomarker should be confirmed and validated using hundreds of specimens and should be reproducible, specific and sensitive. Besides the lack of quality in biomarker validation, a number of other key issues can be identified and should be addressed. Therefore, the aim of this article is to discuss a series of interpretative and practical issues that need to be understood and resolved before potential biomarkers become a clinically approved test or are already on the diagnostic market. Some of these issues are shortly discussed here. read more read less

Topics:

Biomarker discovery (56%)56% related to the paper
View PDF
279 Citations
open accessOpen access Journal Article DOI: 10.1186/S13167-016-0072-4
Medicine in the early twenty-first century: Paradigm and anticipation - EPMA position paper 2016
25 Oct 2016 - The Epma Journal

Abstract:

Background Challenges of “standardisation” and “individualisation” have always been characteristic for medical services. In terms of individualisation, the best possible individual care is the ethical imperative of medicine, and it is a good right of any patient to receive it. However, in terms of standardisation, all the ava... Background Challenges of “standardisation” and “individualisation” have always been characteristic for medical services. In terms of individualisation, the best possible individual care is the ethical imperative of medicine, and it is a good right of any patient to receive it. However, in terms of standardisation, all the available treatments are based on guideline recommendations derived from large multicentre trials with many thousands of patients involved. In the most optimal way, the standardisation and individualisation should go hand-in-hand, in order to identify the right patient treating him/her with the right medication and the right dose at the right time point! Further, in paradigm and anticipation, there is a big discrepancy between “disease care” and “health care” which dramatically impacts ethical and economical aspects of medical services. Several approaches have been suggested in ancient and modern medicine to conduct medical services in a possibly optimal way. What is the difference amongst all of them and how big is the potential beyond corresponding approach to satisfy the needs of the individual, the patient, professional groups involved and society at large? On behalf of the “European Association for Predictive, Preventive and Personalised Medicine,” the dedicated EPMA working group provides a deep analysis in the issue followed by the expert recommendations considering the multifaceted aspects of both “disease care” and “health care” practices including ethics and economy, life quality of individuals and patients, interests of professional groups involved, benefits of subpopulations, health care system(s) and society as a whole. read more read less

Topics:

Anticipation (artificial intelligence) (54%)54% related to the paper
View PDF
271 Citations
open accessOpen access Journal Article DOI: 10.1186/1878-5085-4-14
The primary vascular dysregulation syndrome: implications for eye diseases
Josef Flammer1, Katarzyna Konieczka1, Andreas J. Flammer2
07 Jun 2013 - The Epma Journal

Abstract:

Vascular dysregulation refers to the regulation of blood flow that is not adapted to the needs of the respective tissue. We distinguish primary vascular dysregulation (PVD, formerly called vasospastic syndrome) and secondary vascular dysregulation (SVD). Subjects with PVD tend to have cold extremities, low blood pressure, red... Vascular dysregulation refers to the regulation of blood flow that is not adapted to the needs of the respective tissue. We distinguish primary vascular dysregulation (PVD, formerly called vasospastic syndrome) and secondary vascular dysregulation (SVD). Subjects with PVD tend to have cold extremities, low blood pressure, reduced feeling of thirst, altered drug sensitivity, increased pain sensitivity, prolonged sleep onset time, altered gene expression in the lymphocytes, signs of oxidative stress, slightly increased endothelin-1 plasma level, low body mass index and often diffuse and fluctuating visual field defects. Coldness, emotional or mechanical stress and starving can provoke symptoms. Virtually all organs, particularly the eye, can be involved. In subjects with PVD, retinal vessels are stiffer and more irregular, and both neurovascular coupling and autoregulation capacity are reduced while retinal venous pressure is often increased. Subjects with PVD have increased risk for normal-tension glaucoma, optic nerve compartment syndrome, central serous choroidopathy, Susac syndrome, retinal artery and vein occlusions and anterior ischaemic neuropathy without atherosclerosis. Further characteristics are their weaker blood–brain and blood-retinal barriers and the higher prevalence of optic disc haemorrhages and activated astrocytes. Subjects with PVD tend to suffer more often from tinnitus, muscle cramps, migraine with aura and silent myocardial ischaemic and are at greater risk for altitude sickness. While the main cause of vascular dysregulation is vascular endotheliopathy, dysfunction of the autonomic nervous system is also involved. In contrast, SVD occurs in the context of other diseases such as multiple sclerosis, retrobulbar neuritis, rheumatoid arthritis, fibromyalgia and giant cell arteritis. Taking into consideration the high prevalence of PVD in the population and potentially linked pathologies, in the current article, the authors provide recommendations on how to effectively promote the field in order to create innovative diagnostic tools to predict the pathology and develop more efficient treatment approaches tailored to the person. read more read less

Topics:

Flammer syndrome (53%)53% related to the paper, Population (51%)51% related to the paper, Susac Syndrome (51%)51% related to the paper
View PDF
239 Citations
open accessOpen access Journal Article DOI: 10.1186/S13167-016-0065-3
Tear fluid biomarkers in ocular and systemic disease: potential use for predictive, preventive and personalised medicine.
Suzanne Hagan1, Eilidh Martin1, Amalia Enríquez-de-Salamanca2
13 Jul 2016 - The Epma Journal

Abstract:

In the field of predictive, preventive and personalised medicine, researchers are keen to identify novel and reliable ways to predict and diagnose disease, as well as to monitor patient response to therapeutic agents. In the last decade alone, the sensitivity of profiling technologies has undergone huge improvements in detect... In the field of predictive, preventive and personalised medicine, researchers are keen to identify novel and reliable ways to predict and diagnose disease, as well as to monitor patient response to therapeutic agents. In the last decade alone, the sensitivity of profiling technologies has undergone huge improvements in detection sensitivity, thus allowing quantification of minute samples, for example body fluids that were previously difficult to assay. As a consequence, there has been a huge increase in tear fluid investigation, predominantly in the field of ocular surface disease. As tears are a more accessible and less complex body fluid (than serum or plasma) and sampling is much less invasive, research is starting to focus on how disease processes affect the proteomic, lipidomic and metabolomic composition of the tear film. By determining compositional changes to tear profiles, crucial pathways in disease progression may be identified, allowing for more predictive and personalised therapy of the individual. This article will provide an overview of the various putative tear fluid biomarkers that have been identified to date, ranging from ocular surface disease and retinopathies to cancer and multiple sclerosis. Putative tear fluid biomarkers of ocular disorders, as well as the more recent field of systemic disease biomarkers, will be shown. read more read less
View PDF
222 Citations
open accessOpen access Journal Article DOI: 10.1186/1878-5085-3-14
General report & recommendations in predictive, preventive and personalised medicine 2012: white paper of the European Association for Predictive, Preventive and Personalised Medicine.
Olga Golubnitschaja1, Vincenzo Costigliola
01 Nov 2012 - The Epma Journal

Abstract:

This report is the collective product of word-leading experts working in the branches of integrative medicine by predictive, preventive and personalised medicine (PPPM) under the coordination of the European Association for Predictive, Preventive and Personalised Medicine. The general report has been prepared as the consortiu... This report is the collective product of word-leading experts working in the branches of integrative medicine by predictive, preventive and personalised medicine (PPPM) under the coordination of the European Association for Predictive, Preventive and Personalised Medicine. The general report has been prepared as the consortium document proposed at the EPMA World Congress 2011 which took place in Bonn, Germany. This forum analyzed the overall deficits and trends relevant for the top-science and daily practice in PPPM focused on the patient. Follow-up consultations resulted in a package of recommendations for consideration by research units, educators, healthcare industry, policy-makers, and funding bodies to cover the current knowledge deficit in the field and to introduce integrative approaches for advanced diagnostics, targeted prevention, treatments tailored to the person and cost-effective healthcare. read more read less

Topics:

Integrative medicine (58%)58% related to the paper, Knowledge deficit (53%)53% related to the paper
View PDF
206 Citations
Author Pic

SciSpace is a very innovative solution to the formatting problem and existing providers, such as Mendeley or Word did not really evolve in recent years.

- Andreas Frutiger, Researcher, ETH Zurich, Institute for Biomedical Engineering

Get MS-Word and LaTeX output to any Journal within seconds
1
Choose a template
Select a template from a library of 40,000+ templates
2
Import a MS-Word file or start fresh
It takes only few seconds to import
3
View and edit your final output
SciSpace will automatically format your output to meet journal guidelines
4
Submit directly or Download
Submit to journal directly or Download in PDF, MS Word or LaTeX

(Before submission check for plagiarism via Turnitin)

clock Less than 3 minutes

What to expect from SciSpace?

Speed and accuracy over MS Word

''

With SciSpace, you do not need a word template for EPMA Journal.

It automatically formats your research paper to Springer formatting guidelines and citation style.

You can download a submission ready research paper in pdf, LaTeX and docx formats.

Time comparison

Time taken to format a paper and Compliance with guidelines

Plagiarism Reports via Turnitin

SciSpace has partnered with Turnitin, the leading provider of Plagiarism Check software.

Using this service, researchers can compare submissions against more than 170 million scholarly articles, a database of 70+ billion current and archived web pages. How Turnitin Integration works?

Turnitin Stats
Publisher Logos

Freedom from formatting guidelines

One editor, 100K journal formats – world's largest collection of journal templates

With such a huge verified library, what you need is already there.

publisher-logos

Easy support from all your favorite tools

EPMA Journal format uses SPBASIC citation style.

Automatically format and order your citations and bibliography in a click.

SciSpace allows imports from all reference managers like Mendeley, Zotero, Endnote, Google Scholar etc.

Frequently asked questions

1. Can I write EPMA Journal in LaTeX?

Absolutely not! Our tool has been designed to help you focus on writing. You can write your entire paper as per the EPMA Journal guidelines and auto format it.

2. Do you follow the EPMA Journal guidelines?

Yes, the template is compliant with the EPMA Journal guidelines. Our experts at SciSpace ensure that. If there are any changes to the journal's guidelines, we'll change our algorithm accordingly.

3. Can I cite my article in multiple styles in EPMA Journal?

Of course! We support all the top citation styles, such as APA style, MLA style, Vancouver style, Harvard style, and Chicago style. For example, when you write your paper and hit autoformat, our system will automatically update your article as per the EPMA Journal citation style.

4. Can I use the EPMA Journal templates for free?

Sign up for our free trial, and you'll be able to use all our features for seven days. You'll see how helpful they are and how inexpensive they are compared to other options, Especially for EPMA Journal.

5. Can I use a manuscript in EPMA Journal that I have written in MS Word?

Yes. You can choose the right template, copy-paste the contents from the word document, and click on auto-format. Once you're done, you'll have a publish-ready paper EPMA Journal that you can download at the end.

6. How long does it usually take you to format my papers in EPMA Journal?

It only takes a matter of seconds to edit your manuscript. Besides that, our intuitive editor saves you from writing and formatting it in EPMA Journal.

7. Where can I find the template for the EPMA Journal?

It is possible to find the Word template for any journal on Google. However, why use a template when you can write your entire manuscript on SciSpace , auto format it as per EPMA Journal's guidelines and download the same in Word, PDF and LaTeX formats? Give us a try!.

8. Can I reformat my paper to fit the EPMA Journal's guidelines?

Of course! You can do this using our intuitive editor. It's very easy. If you need help, our support team is always ready to assist you.

9. EPMA Journal an online tool or is there a desktop version?

SciSpace's EPMA Journal is currently available as an online tool. We're developing a desktop version, too. You can request (or upvote) any features that you think would be helpful for you and other researchers in the "feature request" section of your account once you've signed up with us.

10. I cannot find my template in your gallery. Can you create it for me like EPMA Journal?

Sure. You can request any template and we'll have it setup within a few days. You can find the request box in Journal Gallery on the right side bar under the heading, "Couldn't find the format you were looking for like EPMA Journal?”

11. What is the output that I would get after using EPMA Journal?

After writing your paper autoformatting in EPMA Journal, you can download it in multiple formats, viz., PDF, Docx, and LaTeX.

12. Is EPMA Journal's impact factor high enough that I should try publishing my article there?

To be honest, the answer is no. The impact factor is one of the many elements that determine the quality of a journal. Few of these factors include review board, rejection rates, frequency of inclusion in indexes, and Eigenfactor. You need to assess all these factors before you make your final call.

13. What is Sherpa RoMEO Archiving Policy for EPMA Journal?

SHERPA/RoMEO Database

We extracted this data from Sherpa Romeo to help researchers understand the access level of this journal in accordance with the Sherpa Romeo Archiving Policy for EPMA Journal. The table below indicates the level of access a journal has as per Sherpa Romeo's archiving policy.

RoMEO Colour Archiving policy
Green Can archive pre-print and post-print or publisher's version/PDF
Blue Can archive post-print (ie final draft post-refereeing) or publisher's version/PDF
Yellow Can archive pre-print (ie pre-refereeing)
White Archiving not formally supported
FYI:
  1. Pre-prints as being the version of the paper before peer review and
  2. Post-prints as being the version of the paper after peer-review, with revisions having been made.

14. What are the most common citation types In EPMA Journal?

The 5 most common citation types in order of usage for EPMA Journal are:.

S. No. Citation Style Type
1. Author Year
2. Numbered
3. Numbered (Superscripted)
4. Author Year (Cited Pages)
5. Footnote

15. How do I submit my article to the EPMA Journal?

It is possible to find the Word template for any journal on Google. However, why use a template when you can write your entire manuscript on SciSpace , auto format it as per EPMA Journal's guidelines and download the same in Word, PDF and LaTeX formats? Give us a try!.

16. Can I download EPMA Journal in Endnote format?

Yes, SciSpace provides this functionality. After signing up, you would need to import your existing references from Word or Bib file to SciSpace. Then SciSpace would allow you to download your references in EPMA Journal Endnote style according to Elsevier guidelines.

Fast and reliable,
built for complaince.

Instant formatting to 100% publisher guidelines on - SciSpace.

Available only on desktops 🖥

No word template required

Typset automatically formats your research paper to EPMA Journal formatting guidelines and citation style.

Verifed journal formats

One editor, 100K journal formats.
With the largest collection of verified journal formats, what you need is already there.

Trusted by academicians

I spent hours with MS word for reformatting. It was frustrating - plain and simple. With SciSpace, I can draft my manuscripts and once it is finished I can just submit. In case, I have to submit to another journal it is really just a button click instead of an afternoon of reformatting.

Andreas Frutiger
Researcher & Ex MS Word user
Use this template